Neuromyelitis Optica Clinical Trials in Chapel Hill, North Carolina
2 recruitingChapel Hill, North Carolina
Showing 1–2 of 2 trials
Recruiting
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
Neuromyelitis Optica Spectrum DisorderNMOSDAQP4+ NMOSD
Alexion Pharmaceuticals, Inc.122 enrolled33 locationsNCT05966467
Recruiting
Not Applicable
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
Neuromyelitis Optica
Ad scientiam103 enrolled22 locationsNCT05566769